United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Alcon acquires Aerie Pharmaceuticals to expand eye care business Alcon, an American Swiss medical company specializing in eye care products, has closed the previously announced $930 million… byRaghuram KadariNovember 24, 2022